Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
Mol Cancer. 2023.
PMID: 37596643
Free PMC article.
Review.
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.
Klug LR, Bannon AE, Javidi-Sharifi N, Town A, Fleming WH, VanSlyke JK, Musil LS, Fletcher JA, Tyner JW, Heinrich MC.
Klug LR, et al.
Oncogene. 2019 Feb;38(8):1200-1210. doi: 10.1038/s41388-018-0508-5. Epub 2018 Sep 21.
Oncogene. 2019.
PMID: 30242244
Free PMC article.
Item in Clipboard
Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations.
Traer E, Javidi-Sharifi N, Agarwal A, Dunlap J, English I, Martinez J, Tyner JW, Wong M, Druker BJ.
Traer E, et al.
Blood. 2014 Mar 6;123(10):1516-24. doi: 10.1182/blood-2013-07-518381. Epub 2014 Jan 9.
Blood. 2014.
PMID: 24408322
Free PMC article.
Item in Clipboard
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.
Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, Jaiswal S, Ebert BL, Rodig SJ, Tyner JW, Marto JA, Weinstock DM, Lane AA.
Yoda A, et al.
Nat Med. 2015 Jan;21(1):71-5. doi: 10.1038/nm.3751. Epub 2014 Dec 8.
Nat Med. 2015.
PMID: 25485910
Free PMC article.
Item in Clipboard
Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.
Javidi-Sharifi N, Traer E, Martinez J, Gupta A, Taguchi T, Dunlap J, Heinrich MC, Corless CL, Rubin BP, Druker BJ, Tyner JW.
Javidi-Sharifi N, et al.
Cancer Res. 2015 Mar 1;75(5):880-91. doi: 10.1158/0008-5472.CAN-14-0573. Epub 2014 Nov 28.
Cancer Res. 2015.
PMID: 25432174
Free PMC article.
Item in Clipboard
FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.
Traer E, Martinez J, Javidi-Sharifi N, Agarwal A, Dunlap J, English I, Kovacsovics T, Tyner JW, Wong M, Druker BJ.
Traer E, et al.
Cancer Res. 2016 Nov 15;76(22):6471-6482. doi: 10.1158/0008-5472.CAN-15-3569. Epub 2016 Sep 26.
Cancer Res. 2016.
PMID: 27671675
Free PMC article.
Item in Clipboard
Future Directions in Chronic Phase CML Treatment.
Javidi-Sharifi N, Hobbs G.
Javidi-Sharifi N, et al.
Curr Hematol Malig Rep. 2021 Dec;16(6):500-508. doi: 10.1007/s11899-021-00658-w. Epub 2021 Oct 14.
Curr Hematol Malig Rep. 2021.
PMID: 34648120
Review.
Item in Clipboard
FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.
Javidi-Sharifi N, Martinez J, English I, Joshi SK, Scopim-Ribeiro R, Viola SK, Edwards DK 5th, Agarwal A, Lopez C, Jorgens D, Tyner JW, Druker BJ, Traer E.
Javidi-Sharifi N, et al.
Elife. 2019 Feb 5;8:e40033. doi: 10.7554/eLife.40033.
Elife. 2019.
PMID: 30720426
Free PMC article.
Item in Clipboard
Cite
Cite